Oops! Something went wrong, please try again later.
Soleno is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
AdSign up to receive the latest updates & connect with a Soleno Therapeutics representative. VYKATâ„¢ XR (diazoxide choline) is now approved. Learn more and get updates.
AdWant To Stay Updated? Latest News To Give You The Tools To Invest Smarter. Get critical stock news, insights & in-depth analysis. Join Seeking Alpha Today.
Site visitors: Over 100K in the past month
Top 16 stocks bought · Adjusted amounts · Capital markets expertise
Save
Share
More